Life after lockdown: Research and development

The new normal demands new thinking for research and development

With labs and testing facilities on lockdown, with limited access or understaffed, in-house research and development may be proving both difficult and costly right now.

Imperial’s experts may have the answer to your needs. They can provide reviews on tech you’ve developed, or intend to buy-in, and assess its suitability – saving money and time on R&D. There are also a wide range of new technologies, all available to licence, that have been invented by Imperial’s researchers.

In addition, many of the labs and testing facilities at Imperial are re-opening in order to deliver teaching and research activities, meaning your research and development can be undertaken by leading experts in a range of sectors.

Contact us today to discuss your R&D challenges and our experienced teams will offer solutions that best suit your needs.

Imperial Tech – available to licence

Cleantech

  • Grid Frequency Estimation and Power Fault Detection,
  • Aqueous Conductive Ink for 3D Printing,
  • Novel control for froth flotation cells, 
  • Non-invasive remote condition monitoring to increase machine uptime in Industrial IoT.

Diagnostics

  • MicroRNA Biomarkers for ectopic or intrauterine pregnancy,
  • Transcutaneous fluorescence spectroscopy to assess gut permeability and gastric emptying rate,
  • Single Particle Automated Raman Trapping Analysis,
  • MicroRNA plasma markers for preterm labour,
  • Aptamer-based multiplex screening platform,
  • Smartphone Ballistocardiogram App,
  • TB Diagnostic Gene Signature.

Engineering & Materials

  • Seismic Metamaterials vibration shield for buildings
  • 3D Printing with polygrain lattices for lightweight but tough structures
  • Neural Network Wireless IoT Device
  • Low Weight Portable Wireless Power Transfer
  • Non-invasive, remote condition monitoring to increase machine uptime in Industrial IoT
  • A new filter to remove Arsenic in drinking water
  • Fast warm stamping of ultra-high strength steel sheets

ICT / Digital

  • Neural Network Wireless IoT Device
  • Smart contracts that lawyers can program
  • Autonomous System Safety: Model-Checker Toolkit
  • Non-invasive remote condition monitoring to increase machine uptime in Industrial IoT.

Medtech

  • Portable laser for skin surgery & aesthetic treatments using off-the-shelf LEDs as light source.
  • Transcutaneous fluorescence spectroscopy to assess gut permeability and gastric emptying rate,
  • Biomimetic osteochondral scaffold
  • Neural implant technology for brain machine interfaces
  • Voltage measurement for cancerous tissues
  • Endoscopic scanning probe for rapid screening of hollow organs dysplasia
  • Wide Clip and Applicator for Minimally Invasive Surgery

Platform Tech

  • Novel vortex laser
  • Vaccine development using modified Viral-like Particles (VLPs)
  • Single Particle Automated Raman Trapping Analysis
  • Phage/AAV delivery vector for gene therapy, medical imaging and vaccine delivery
  • Large-scale method of production of AAVs
  • Multi-functional bacteriophages for targeted gene therapy
  • Aptamer-based multiplex screening platform 

Find out how Imperial can help you with your specific needs be they immediate or a longer term goal.

Latest news

Tackling London’s air pollution will increase life expectancy of children

Tackling London’s air pollution will increase life expectancy of children

Report by researchers from Environmental Research Group predicts London air quality policies, and wider improvements in air quality, will increase average life expectancy of a child born in London in 2013 by six months. read more

Press release: MedCity-led university Testing Alliance to offer 20,500 extra daily COVID-19 tests

Press release: MedCity-led university Testing Alliance to offer 20,500 extra daily COVID-19 tests

London’s leading life science and academic institutions have united to respond in an unprecedented way to the coronavirus pandemic by ramping up diagnostic testing capacity for the UK. read more

Imperial’s COVID-19 vaccine explained

Imperial’s COVID-19 vaccine explained

As the first trials of Imperial’s COVID-19 vaccine candidate got underway in June, Professor Robin Shattock, Dr Katrina Pollock and Dr David Owen explain how the vaccine works, how it’s being trialled, and plans to help it reach populations around the world, if it proves to be effective in protecting people against COVID-19. read more

Related case studies

Imperial College London Diabetes Centre

Imperial College London Diabetes Centre

The Imperial College London Diabetes Centre was established in Abu Dhabi, in 2006, by Mubadala and experts from Imperial to address the demand for diabetes care in the UAE. With continued support from Imperial, the centre now operates three branches across Abu Dhabi and Al Ain and public health initiatives. read more

Imperial COVID-19 testing facilities

Imperial COVID-19 testing facilities

Imperial's facility, comprising the UKAS accredited Molecular Diagnostic Unit (MDU) and high-throughput robotic platform for RNA extraction, forms part of the Department of Health and Social Care's partnership with the London Testing Alliance, set-up by MedCity. read more